Global Cell And Gene Therapy Market Overview:
Global Cell And Gene Therapy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Cell And Gene Therapy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Cell And Gene Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Cell And Gene Therapy Market:
The Cell And Gene Therapy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Cell And Gene Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Cell And Gene Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Cell And Gene Therapy market has been segmented into:
Cell Therapy (Stem Cells
T Cells
Dendritic Cells
and NK Cells
By Application, Cell And Gene Therapy market has been segmented into:
Dermatology
Musculoskeletal
Oncology
Immunology
Cardiology
Neurology
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cell And Gene Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Cell And Gene Therapy market.
Top Key Players Covered in Cell And Gene Therapy market are:
Bristol-Myers Squibb Company (Celgene Corporation)
Pfizer
Inc.
Novartis AG
bluebird bio
Inc.
Gilead Sciences
Inc. (Kite Pharma
Inc.)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Cell And Gene Therapy Market Type
4.1 Cell And Gene Therapy Market Snapshot and Growth Engine
4.2 Cell And Gene Therapy Market Overview
4.3 Cell Therapy (Stem Cells
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Cell Therapy (Stem Cells: Geographic Segmentation Analysis
4.4 T Cells
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 T Cells: Geographic Segmentation Analysis
4.5 Dendritic Cells
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Dendritic Cells: Geographic Segmentation Analysis
4.6 and NK Cells
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 and NK Cells: Geographic Segmentation Analysis
Chapter 5: Cell And Gene Therapy Market Application
5.1 Cell And Gene Therapy Market Snapshot and Growth Engine
5.2 Cell And Gene Therapy Market Overview
5.3 Dermatology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Dermatology: Geographic Segmentation Analysis
5.4 Musculoskeletal
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Musculoskeletal: Geographic Segmentation Analysis
5.5 Oncology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Oncology: Geographic Segmentation Analysis
5.6 Immunology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Immunology: Geographic Segmentation Analysis
5.7 Cardiology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Cardiology: Geographic Segmentation Analysis
5.8 Neurology
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Neurology: Geographic Segmentation Analysis
5.9 and Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.9.3 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Cell And Gene Therapy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BRISTOL-MYERS SQUIBB COMPANY (CELGENE CORPORATION)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 PFIZER
6.4 INC.
6.5 NOVARTIS AG
6.6 BLUEBIRD BIO
6.7 INC.
6.8 GILEAD SCIENCES
6.9 INC. (KITE PHARMA
6.10 INC.)
Chapter 7: Global Cell And Gene Therapy Market By Region
7.1 Overview
7.2. North America Cell And Gene Therapy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Cell Therapy (Stem Cells
7.2.2.2 T Cells
7.2.2.3 Dendritic Cells
7.2.2.4 and NK Cells
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Dermatology
7.2.3.2 Musculoskeletal
7.2.3.3 Oncology
7.2.3.4 Immunology
7.2.3.5 Cardiology
7.2.3.6 Neurology
7.2.3.7 and Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Cell And Gene Therapy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Cell Therapy (Stem Cells
7.3.2.2 T Cells
7.3.2.3 Dendritic Cells
7.3.2.4 and NK Cells
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Dermatology
7.3.3.2 Musculoskeletal
7.3.3.3 Oncology
7.3.3.4 Immunology
7.3.3.5 Cardiology
7.3.3.6 Neurology
7.3.3.7 and Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Cell And Gene Therapy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Cell Therapy (Stem Cells
7.4.2.2 T Cells
7.4.2.3 Dendritic Cells
7.4.2.4 and NK Cells
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Dermatology
7.4.3.2 Musculoskeletal
7.4.3.3 Oncology
7.4.3.4 Immunology
7.4.3.5 Cardiology
7.4.3.6 Neurology
7.4.3.7 and Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Cell And Gene Therapy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Cell Therapy (Stem Cells
7.5.2.2 T Cells
7.5.2.3 Dendritic Cells
7.5.2.4 and NK Cells
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Dermatology
7.5.3.2 Musculoskeletal
7.5.3.3 Oncology
7.5.3.4 Immunology
7.5.3.5 Cardiology
7.5.3.6 Neurology
7.5.3.7 and Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Cell And Gene Therapy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Cell Therapy (Stem Cells
7.6.2.2 T Cells
7.6.2.3 Dendritic Cells
7.6.2.4 and NK Cells
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Dermatology
7.6.3.2 Musculoskeletal
7.6.3.3 Oncology
7.6.3.4 Immunology
7.6.3.5 Cardiology
7.6.3.6 Neurology
7.6.3.7 and Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Cell And Gene Therapy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Cell Therapy (Stem Cells
7.7.2.2 T Cells
7.7.2.3 Dendritic Cells
7.7.2.4 and NK Cells
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Dermatology
7.7.3.2 Musculoskeletal
7.7.3.3 Oncology
7.7.3.4 Immunology
7.7.3.5 Cardiology
7.7.3.6 Neurology
7.7.3.7 and Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Cell And Gene Therapy Scope:
|
Report Data
|
Cell And Gene Therapy Market
|
|
Cell And Gene Therapy Market Size in 2025
|
USD XX million
|
|
Cell And Gene Therapy CAGR 2025 - 2032
|
XX%
|
|
Cell And Gene Therapy Base Year
|
2024
|
|
Cell And Gene Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bristol-Myers Squibb Company (Celgene Corporation), Pfizer, Inc., Novartis AG, bluebird bio, Inc., Gilead Sciences, Inc. (Kite Pharma, Inc.).
|
|
Key Segments
|
By Type
Cell Therapy (Stem Cells
T Cells
Dendritic Cells
and NK Cells
By Applications
Dermatology
Musculoskeletal
Oncology
Immunology
Cardiology
Neurology
and Others
|
